BioPontis Alliance for Rare Diseases is celebrating the completion of our first full year of operations.

BioPontis Alliance for Rare Diseases is celebrating the completion of our first full year of operations.

April 3, 2017

BioPontis Alliance for Rare Diseases is celebrating the completion of our first full year of operations. We have created an Annual Report to share our achievements with you.

Click to Read 2016 BioPontis Annual Report
Click to Read 2016 BioPontis Annual Report (A4 version)


About BioPontis Alliance for Rare Diseases

BioPontis Alliance for Rare Diseases is a 501c(3) public charity in the US (North Carolina) and a foundation of public utility (fup/son) in Belgium (Brussels). Managed by an international Board and executive team, BioPontis partners with patient organizations and clinical researchers to bridge the gap between promising science and new medicines. BioPontis Alliance for Rare Diseases is being established as a global non-profit, inviting corporate, private and foundation philanthropic support. More information, including how contributions to support our programs and mission can be made, at http://biopontisalliance.org.

 

Contacts:

Erik Tambuyzer, Chairperson
+32 475 615711 (Brussels, Belgium)
erik.tambuyzer@biopontisalliance.org

Barbara Handelin, CEO
+1 610.636.2332 (Philadelphia, USA)
barbara.handelin@biopontisalliance.org

Richard Basile, COO
+1 919.345.5386 (Raleigh, USA)
richard.basile@biopontisalliance.org